Lee Yun Mi, Jo Kyuhyung, Kim So Yeon, Seo Chang-Seob, Son Eunjung, Kim Aejin, Kim Dong-Seon
KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
KM Convergence Research Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.
Pharmaceuticals (Basel). 2025 Jan 2;18(1):44. doi: 10.3390/ph18010044.
: Yeokwisan (YWS) is a standardised herbal formula for relieving functional dyspepsia symptoms. : We explored the therapeutic value of YWS and its potential effects on gastritis. Its inhibitory effect on gastric mucosal damage and anti-inflammatory activity in animal models of alcohol- and restraint stress-induced gastritis were also examined. Gastric tissues of ICR mice treated with YWS (150 and 300 mg/kg) or famotidine (5 mg/kg) for 10 days were collected, and gastric lesions were quantified. The stomachs of C57BL/6 mice treated with YWS (150 and 300 mg/kg) or famotidine (5 mg/kg) for 23 days were collected, and gastric lesions were quantified. Blood samples were analysed for inflammation related factors and gastroprotective effects. : YWS (300 mg/kg) inhibited gastric damage by 42.33% in the EtOH-induced gastritis model and 75% in the restraint stress-induced gastritis model (compared to the control group). Pretreatment with YWS led to decreased levels of inflammatory factors (IL-1β, IL-6, and COX-2). YWS showed gastroprotective effects through histamine downregulation, while prostaglandin E2 (PGE2) and mucin were upregulated. The mRNA levels of H2R, M3R, CCK2R, and H/K ATPase were significantly decreased following treatment with YWS. YWS provides gastric protection through its anti-inflammatory properties, reduced histamine secretion, and enhanced release of mucosal defensive factors.
胃可安(YWS)是一种用于缓解功能性消化不良症状的标准化草药配方。我们探究了胃可安的治疗价值及其对胃炎的潜在影响。还检测了其在酒精和束缚应激诱导的胃炎动物模型中对胃黏膜损伤的抑制作用和抗炎活性。收集用胃可安(150和300毫克/千克)或法莫替丁(5毫克/千克)处理10天的ICR小鼠的胃组织,并对胃损伤进行定量分析。收集用胃可安(150和300毫克/千克)或法莫替丁(5毫克/千克)处理23天的C57BL/6小鼠的胃,并对胃损伤进行定量分析。对血液样本进行炎症相关因子和胃保护作用分析。在乙醇诱导的胃炎模型中,胃可安(300毫克/千克)使胃损伤抑制了42.33%,在束缚应激诱导的胃炎模型中抑制了75%(与对照组相比)。胃可安预处理导致炎症因子(IL-1β、IL-6和COX-2)水平降低。胃可安通过下调组胺显示出胃保护作用,同时上调前列腺素E2(PGE2)和黏蛋白。用胃可安处理后,H2R、M3R、CCK2R和H/K ATP酶的mRNA水平显著降低。胃可安通过其抗炎特性、减少组胺分泌和增强黏膜防御因子释放来提供胃保护。